The largest human trial ever attempted, a phase 1 study with 42 volunteers, was canceled in 2016 and never published results, leaving fewer than 30 people studied in any formal published human research on this compound
Reyes CD, Petrie TA, Burns KL, Schwartz Z, Garcia AJ
The Food and Drug Administration (FDA) has approved bupropion, a norepinephrine dopamine reuptake inhibitor (NDRI), varenicline, an 4 2 nicotinic agonist, as well as nicotine replacement therapies (NRTs) for NUD [6,7,8,9]
However, it remains unclear how this physical signal affects other hallmarks of cancer, including drug resistance and angiogenesis
This approach enhances the precision of target identification and helps map the complex interaction networks of bioactive components
The trick is to ease into it